Posted by & filed under Financial analysis, Governments & Regulators, Growth & Valuation, Management Issues.

Description: The story of a young former hedge fund manager buying a lifesaving drug and then jacking up the price by more than 5,000% has ignited a firestorm.


Date: Sep 24, 2015


Questions for discussion:

  • Summarize the arguments presented in this report.
  • Where do you stand with respect to the behavior of this firm and its management?

Leave a Reply

Your email address will not be published. Required fields are marked *